|
|
||||||||
|
FIGURE 2. Whole-body and transaxial images of 99mTc-(Arg11)CCMSH (A and B, respectively) and 111In-DOTA-Re(Arg11)CCMSH (D and C, respectively) in B16/F1 flank melanoma-bearing C57 mice at 2 h after injection. Whole-body and transaxial images of 99mTc-(Arg11)CCMSH (E and F, respectively) and 111In-DOTA-Re(Arg11)CCMSH (H and G, respectively) in B16/F10 pulmonary metastatic melanoma-bearing C57 mice 2 h after injection.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |